PLA2G7 antibody (AA 33-441)
Quick Overview for PLA2G7 antibody (AA 33-441) (ABIN7570124)
Target
See all PLA2G7 (Lp-PLA2) AntibodiesReactivity
Host
Clonality
Conjugate
Application
-
-
Binding Specificity
- AA 33-441
-
Purpose
- Anti-LpPLA2/PLA2G7/PAF-AH Polyclonal antibody
-
Purification
- Antigen affinity purification.
-
Immunogen
- E. coli - derived recombinant Human LpPLA2 / PLA2G7 / PAF-AH (Met33-Asn441).
-
Isotype
- IgG
-
-
-
-
Application Notes
- Optimal working dilution should be determined by the investigator.
-
Restrictions
- For Research Use only
-
-
-
Format
- Liquid
-
Buffer
- 0.01M PBS, pH 7.4, 50 % glycerol, 0.05 % Proclin 300.
-
Preservative
- ProClin
-
Precaution of Use
- This product contains ProClin: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Storage
- 4 °C,-20 °C,-80 °C
-
Storage Comment
- Use a manual defrost freezer and avoid repeated freeze thaw cycles.Store at 4°C for frequent use.Store at -20 to -80 °C for twelve months from the date of receipt.
-
-
- PLA2G7 (Lp-PLA2) (Lipoprotein-Associated phospholipase A2 (Lp-PLA2))
-
Alternative Name
- LpPLA2
-
Background
- Platelet-activating factor acetylhydrolase,PAFAH,PAF 2-acylhydrolase,PAF acetylhydrolase,2-acetyl-1-alkylglycerophosphocholine esterase,1-alkyl-2-acetylglycerophosphocholine esterase,LDL-PLA(2),LDL-associated phospholipase A2,PLA2G7,Group-VIIA phospholipase A2,gVIIA-PLA2,
-
UniProt
- Q13093
-
Pathways
- Peptide Hormone Metabolism
Target
-